Literature DB >> 23503463

Context-specific regulation of cancer epigenomes by histone and transcription factor methylation.

M Sarris1, K Nikolaou1, I Talianidis1.   

Abstract

Altered expression or activity of histone lysine methylases and demethylases in cancer lead to aberrant chromatin modification patterns, which contribute to uncontrolled cell proliferation via cancer-specific deregulation of gene expression programs or the induction of genome instability. Several transcription factors that regulate growth-associated genes undergo lysine methylation, expanding the repertoire of regulatory targets modulated by histone-methylating enzymes during tumorigenesis. In certain specific tumor types or specific physiological conditions, these enzymes may trigger chromatin structure and/or transcription factor activity changes that result in opposite effects on cancer initiation or progression. The mechanisms of such context-specific dual functions and those involved in the crosstalk between factor and histone modifications are subject to extensive research, which is beginning to shed light into this novel level of complexity of cancer-related epigenetic pathways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23503463     DOI: 10.1038/onc.2013.87

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

Review 1.  Metabolic regulation of histone post-translational modifications.

Authors:  Jing Fan; Kimberly A Krautkramer; Jessica L Feldman; John M Denu
Journal:  ACS Chem Biol       Date:  2015-01-16       Impact factor: 5.100

2.  Mechanism of gene-specificity of oncogenic regulators.

Authors:  Panagiotis Moulos; Michalis E Sarris; Iannis Talianidis
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

3.  Curcumin and dimethoxycurcumin induced epigenetic changes in leukemia cells.

Authors:  Hazem E Hassan; Samuel Carlson; Inas Abdallah; Thomm Buttolph; Karen C Glass; Tamer E Fandy
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

4.  A developmental genetic analysis of the lysine demethylase KDM2 mutations in Drosophila melanogaster.

Authors:  Yani Zheng; Fu-Ning Hsu; Wu Xu; Xiao-Jun Xie; Xinjie Ren; Xinsheng Gao; Jian-Quan Ni; Jun-Yuan Ji
Journal:  Mech Dev       Date:  2014-07-09       Impact factor: 1.882

5.  Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.

Authors:  Changyu Zhu; Yu-Jui Ho; Marcela A Salomao; Dianne H Dapito; Alberto Bartolome; Robert F Schwabe; Ju-Seog Lee; Scott W Lowe; Utpal B Pajvani
Journal:  J Hepatol       Date:  2020-10-08       Impact factor: 25.083

6.  Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.

Authors:  S Komatsu; D Ichikawa; S Hirajima; H Nagata; Y Nishimura; T Kawaguchi; M Miyamae; W Okajima; T Ohashi; H Konishi; A Shiozaki; H Fujiwara; K Okamoto; H Tsuda; I Imoto; J Inazawa; E Otsuji
Journal:  Br J Cancer       Date:  2014-10-16       Impact factor: 7.640

7.  A property-based analysis of human transcription factors.

Authors:  Shahram Bahrami; Rezvan Ehsani; Finn Drabløs
Journal:  BMC Res Notes       Date:  2015-03-14

Review 8.  Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets.

Authors:  Giuseppe Palmieri; MariaNeve Ombra; Maria Colombino; Milena Casula; MariaCristina Sini; Antonella Manca; Panagiotis Paliogiannis; Paolo Antonio Ascierto; Antonio Cossu
Journal:  Front Oncol       Date:  2015-08-10       Impact factor: 6.244

9.  SET9-Mediated Regulation of TGF-β Signaling Links Protein Methylation to Pulmonary Fibrosis.

Authors:  Maximilianos Elkouris; Haroula Kontaki; Athanasios Stavropoulos; Anastasia Antonoglou; Kostas C Nikolaou; Martina Samiotaki; Eszter Szantai; Dimitra Saviolaki; Peter J Brown; Paschalis Sideras; George Panayotou; Iannis Talianidis
Journal:  Cell Rep       Date:  2016-06-09       Impact factor: 9.423

10.  Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.

Authors:  Bing-Hao Wu; Hui Chen; Chun-Miao Cai; Jia-Zhu Fang; Chong-Chao Wu; Li-Yu Huang; Lan Wang; Ze-Guang Han
Journal:  Oncotarget       Date:  2016-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.